INS and diabetes mellitus: Importantly, in the in vivo study using diabetes rat models induced by streptozotocin (STZ), the nanoparticles could reduce the glucose blood level to the normal rate, increase the resistance of insulin and the resistance of plasma fibroblast growth factor 21 (FGF 21), compared to the free form.